Which companies are developing vaccines for norovirus?

Vaxart is not the only company working on a vaccine for the norovirus. Japan-based Takeda Pharmaceuticals also has a vaccine in the clinic, although this one is an injectable. Latour said Takeda has blazed a trail in the field for norovirus vaccine development. read more

I believe that a vaccine for norovirus would be beneficial for both developed and developing countries. It is the cause of about 1 in 5 cases of acute gastroenteritis in developed countries. It is a smaller fraction (1/6) for developing countries overall because more cases are due to various other pathogens, but there are less resources in those countries which leads to more possible deaths due to dehydration. read more

Osaka, Japan, June 20, 2016 – Takeda Pharmaceutical Company Limited , (“Takeda”) today announced that it has dosed the first subject in a Phase 2b field efficacy trial of Takeda’s norovirus vaccine candidate (TAK-214), the only norovirus vaccine candidate in human clinical trials. read more

Because a norovirus vaccine is expected to have a dual market in both developed and developing countries, there would likely be scale-up advantages for commercial development and global distribution. Combination with or expression by another enteric pathogen, such as rotavirus, could also enhance uptake of a norovirus vaccine. read more